SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-18-047291
Filing Date
2018-02-15
Accepted
2018-02-15 16:32:07
Documents
1
Group Members
SK IMPACT FUND, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d538542dsc13da.htm SC 13D/A 43620
  Complete submission text file 0001193125-18-047291.txt   44884
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Subject) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83614 | Film No.: 18618141
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7501 WISCONSIN AVENUE SUITE 600E BETHESDA MD 20814
Business Address
Kuno Sachiko (Filed by) CIK: 0001383384 (see all company filings)

Type: SC 13D/A